| Literature DB >> 33508789 |
Sung Eun Kim1, Minji Bang1, Eunsoo Won1, Sang-Hyuk Lee1,2.
Abstract
OBJECTIVE: Although neural correlates of sub-clinical agoraphobia (AG) symptoms have been previously suggested, only a few studies evaluating structural changes of the brain have been conducted in agoraphobic patients with panic disorder (PD). We investigated and compared white matter (WM) micro-structural alterations between PD patients with AG (PD + AG) and those without AG (PD - AG).Entities:
Keywords: Agoraphobia; Neuroimaging; Panic disorder; White matter
Year: 2021 PMID: 33508789 PMCID: PMC7851457 DOI: 10.9758/cpn.2021.19.1.63
Source DB: PubMed Journal: Clin Psychopharmacol Neurosci ISSN: 1738-1088 Impact factor: 2.582
Fig. 13D reconstructions of the regions of interest.
Demographic and clinical characteristics of the panic disorder participants
| Variable | PD − AG (n = 31) | PD + AG (n = 25) | Statistics | |
|---|---|---|---|---|
|
| ||||
|
|
| |||
| Age (yr) | 35.52 ± 10.83 | 38.44 ± 10.53 | −1.02 | 0.314 |
| Education (yr) | 13.32 ± 2.99 | 13.08 ± 3.17 | 0.30 | 0.766 |
| Intracranial volumes (mm3) | 1,400.27 ± 119.08 | 1,361.63 ± 87.28 | 1.14 | 0.262 |
| BDI-II, total score | 15.06 ± 7.58 | 22.96 ± 10.75 | −3.19 | 0.002 |
| BAI, total score | 23.10 ± 11.52 | 36.17 ± 13.57 | −3.86 | 0.000 |
| ASI-R, total score | 44.97 ± 19.20 | 68.46 ± 29.22 | −3.38 | 0.002 |
| APPQ, total score | 31.94 ± 21.38 | 105.58 ± 35.03 | −9.08 | 0.000 |
| Agoraphobia | 10.77 ± 7.11 | 44.16 ± 13.06 | −11.48 | 0.000 |
| Social phobia | 10.00 ± 8.85 | 30.40 ± 17.83 | −5.23 | 0.000 |
| Interoception | 11.16 ± 9.98 | 31.29 ± 12.37 | −6.68 | 0.000 |
| SSRI escitalopram equivalent dosage (mg/day) | 7.5 ± 7.33 | 9.40 ± 6.78 | −0.98 | 0.330 |
| Benzodiazepine equivalent dosage (mg/day) | 1.46 ± 1.45 | 1.39 ± 0.73 | −0.21 | 0.830 |
Values are presented as mean ± standard deviation.
PD, panic disorder; AG, agoraphobia; BDI-II, Beck Depression Inventory-II; BAI, Beck Anxiety Inventory; ASI-R, Anxiety Sensitivity Index-Revised; APPQ, Albany Panic and Phobia Questionnaire; SSRI, selective serotonin reuptake inhibitor.
aThe approximate equivalent oral doses to 10 mg escitalopram are given. bThe approximate equivalent oral doses to 1 mg lorazepam are given.
Comparison of FA values of ROIs between PD + AG and PD − AG
| Regions of interest | PD − AG (n = 31) | PD + AG (n = 25) | Statistics | |
|---|---|---|---|---|
|
| ||||
|
|
| |||
| Fornix (column and body) | 0.66 ± 0.13 | 0.62 ± 0.11 | 0.981 | 0.328 |
| Left | ||||
| Inferior longitudinal/ fronto-occipital fasciculus | 0.63 ± 0.03 | 0.63 ± 0.04 | 0.381 | 0.705 |
| Fornix (cres/stria terminals) | 0.65 ± 0.03 | 0.65 ± 0.04 | 0.809 | 0.374 |
| Uncinate fasciculus | 0.63 ± 0.04 | 0.62 ± 0.06 | 3.481 | 0.069 |
| Cingulum bundle | 0.73 ± 0.05 | 0.73 ± 0.04 | 0.388 | 0.669 |
| Right | ||||
| Inferior longitudinal/ fronto-occipital fasciculus | 0.67 ± 0.03 | 0.66 ± 0.03 | 1.158 | 0.252 |
| Fornix (cres/stria terminalis) | 0.71 ± 0.03 | 0.70 ± 0.04 | 0.001 | 0.97 |
| Uncinate fasciculus | 0.65 ± 0.04 | 0.62 ± 0.06 | 4.206 | 0.021 |
| Cingulum bundle | 0.77 ± 0.04 | 0.77 ± 0.04 | 0.322 | 0.541 |
Values are presented as mean ± standard deviation.
FA, fractional anisotropy; ROI, region of interest; PD, panic disorder; AG, agoraphobia.
apvalues were corrected for multiple comparisons using a Benjamini-Hochberg false discovery rate correction method.
Fig. 2Exploratory correlation analysis between FA value of right uncinate fasciculus and clinical symptom severity in PD + AG. PD, panic disorder; AG, agoraphobia; ASI-R, Anxiety Sensitivity Inventory-Revised; BDI-II, Beck Depression Inventory-II.
Fig. 3Exploratory correlation an-alysis between FA value of right un-cinate fasciculus and clinical symptom severity in PD − AG. PD, panic disorder; AG, agoraphobia; APPQ, Albany Panic and Phobia Questionnaire.